DA
Therapeutic Areas
Aptamer Group Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Alzheimer's Disease Diagnostic Reagents | Alzheimer's Disease Biomarker Detection | Development |
| Targeted siRNA Delivery (AstraZeneca Collab) | siRNA Delivery | Discovery/Development |
| Consumer Cosmetic Innovation (Unilever) | Cosmetic Applications | Development |
Leadership Team at Aptamer Group
DA
Dr. Arron Tolley
Chief Executive Officer
DD
Dr. David Bunka
Chief Scientific Officer
AR
Andrew Rapson
Chief Financial Officer and Company Secretary
TS
Tim Sykes
Non-Executive Director
PP
Prof. Paul Townsend
Scientific Advisory Board
DS
Dr. Shozo Fujita
Scientific Advisory Board
DP
Dr. Paloma Giangrande
Scientific Advisory Board
DL
Dr. Louis Allott
Scientific Advisory Board